HOPO Therapeutics
HOPO Therapeutics
Home
About
Company
People
Careers
FAQ
Our Focus Areas
Radiological Hazards
Lead Poisoning
Gadolinium Toxicity
Our Science
Discovery & Development
HOPO 14-1
Publications
News
Contact
Taylor A Choi
Latest
238 Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice
Cite
×